Aquestive Therapeutics Inc (AQST)
3.52
+0.24
(+7.32%)
USD |
NASDAQ |
May 03, 16:00
3.51
-0.01
(-0.28%)
After-Hours: 20:00
Aquestive Therapeutics Gross Profit Margin (Quarterly): 64.57% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 64.57% |
| September 30, 2023 | 63.10% |
| June 30, 2023 | 50.03% |
| March 31, 2023 | 57.45% |
| December 31, 2022 | 50.34% |
| September 30, 2022 | 59.65% |
| June 30, 2022 | 60.48% |
| March 31, 2022 | 65.66% |
| December 31, 2021 | 69.62% |
| September 30, 2021 | 66.88% |
| June 30, 2021 | 70.90% |
| March 31, 2021 | 75.21% |
| December 31, 2020 | 61.00% |
| September 30, 2020 | 63.95% |
| Date | Value |
|---|---|
| June 30, 2020 | 83.67% |
| March 31, 2020 | 58.25% |
| December 31, 2019 | 58.63% |
| September 30, 2019 | 62.61% |
| June 30, 2019 | 51.30% |
| March 31, 2019 | 72.27% |
| December 31, 2018 | 71.55% |
| September 30, 2018 | 57.85% |
| June 30, 2018 | 64.29% |
| March 31, 2018 | 75.93% |
| December 31, 2017 | 53.96% |
| September 30, 2017 | 82.02% |
| June 30, 2017 | 53.86% |
| March 31, 2017 | 74.54% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
50.03%
Minimum
Jun 2023
83.67%
Maximum
Jun 2020
62.81%
Average
62.61%
Median
Sep 2019
Gross Profit Margin (Quarterly) Benchmarks
| Lifecore Biomedical Inc | -- |
| Harrow Inc | 68.91% |
| Akebia Therapeutics Inc | 66.79% |
| 89bio Inc | -- |
| Geron Corp | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -13.47% |
| Profit Margin (Quarterly) | -61.42% |
| Operating Margin (Quarterly) | -29.62% |
| Return on Net Operating Assets | -30.73% |